Articles

Dlk1 is a negative regulator of emerging hematopoietic stem and progenitor cells

Department of Haematology, Cambridge Institute for Medical Research, Wellcome Trust & MRC Stem Cell Institute, University of Cambridge, Cambridge, UK
Erasmus Stem Cell Institute, Department of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands
Department of Haematology, Cambridge Institute for Medical Research, Wellcome Trust & MRC Stem Cell Institute, University of Cambridge, Cambridge, UK
Erasmus Stem Cell Institute, Department of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands
Erasmus Stem Cell Institute, Department of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands
MRC Molecular Haematology Unit, Weatherall Institute for Molecular Medicine, University of Oxford, Oxford, UK
Department of Inorganic and Organic Chemistry and Biochemistry, Medical School, Regional Center for Biomedical Research, University of Castilla-La Mancha, Albacete, Spain
Cellular and Tissue Therapies Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
MRC Molecular Haematology Unit, Weatherall Institute for Molecular Medicine, University of Oxford, Oxford, UK
Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK
Erasmus Stem Cell Institute, Department of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands
Department of Haematology, Cambridge Institute for Medical Research, Wellcome Trust & MRC Stem Cell Institute, University of Cambridge, Cambridge, UK
Vol. 98 No. 2 (2013): February, 2013 https://doi.org/10.3324/haematol.2012.070789